BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Cardiovascular

Hongjiang Li
June 14, 2017 4:55 PM UTC

Cell culture and mouse studies suggest inhibition of TRPC3, TRPC6 and TRPC7 could help treat ischemia/reperfusion injury. In a mouse model of the indication, cardiac tissue levels of TRPC3 and TRPC6 w...

BCIQ Company Profiles

Catholic University of Argentina

Huazhong University of Science and Technology

BCIQ Target Profiles

Transient receptor potential cation channel subfamily C member 3 (TRPC3)

Transient receptor potential cation channel subfamily C member 6 (TRPC6)

Transient receptor potential cation channel subfamily C member 7 (TRPC7)

BCIQ Company Profiles

Catholic University of Argentina

Huazhong University of Science and Technology

BCIQ Target Profiles

Transient receptor potential cation channel subfamily C member 3 (TRPC3)

Transient receptor potential cation channel subfamily C member 6 (TRPC6)

Transient receptor potential cation channel subfamily C member 7 (TRPC7)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS